The effectiveness of an integrated approach to the treatment of patients with melanoma with metastatic brain lessions (clinical observation)
- Autores: Zhukov N.V.1,2, Orlova R.V1,2, Antimonik N.Y.1, Kutukova S.I1,3, Belyak N.P1,2, Vasyusina O.V3, Popova N.V1
-
Afiliações:
- City Clinical Oncology Dispensary
- St. Petersburg State University
- Pavlov First St. Petersburg State Medical University
- Edição: Volume 26, Nº 7 (2019)
- Páginas: 88-95
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/312213
- DOI: https://doi.org/10.18565/pharmateca.2019.7.88-95
- ID: 312213
Citar
Texto integral
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Texto integral
Sobre autores
Nataliya Zhukov
City Clinical Oncology Dispensary; St. Petersburg State University
Email: natalia-zhukova@yandex.ru
Medical Faculty; PhD, Oncologist 56, Veteranov Avenue, St. Petersburg 198255, Russian Federation
R. Orlova
City Clinical Oncology Dispensary; St. Petersburg State UniversityMedical Faculty St. Petersburg, Russia
N. Antimonik
City Clinical Oncology DispensarySt. Petersburg, Russia
S. Kutukova
City Clinical Oncology Dispensary; Pavlov First St. Petersburg State Medical UniversitySt. Petersburg, Russia
N. Belyak
City Clinical Oncology Dispensary; St. Petersburg State UniversityMedical Faculty St. Petersburg, Russia
O. Vasyusina
Pavlov First St. Petersburg State Medical UniversitySt. Petersburg, Russia
N. Popova
City Clinical Oncology DispensarySt. Petersburg, Russia
Bibliografia
- Состояние онкологической помощи населению России в 2017 году. Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2018.
- Zhukova N.V., Orlova R.V., Antimonik N.Yu., et. al. Modern treatment of metastatic melanoma from standards to an individualized approach in real clinical practice. Res Pract Med J. 2018;5(2): 130-40.
- Cohen J.V., Tawbi H., Margolin K.A., et al. Melanoma central nervous system metastases: current approaches, challenges, and opportunities. Pigment Cell Melanoma Res. 2016;29:627-42. doi: 10.1111/pcmr.12538.
- Sampson J.H., Carter J.H. Jr., Friedman A.H., Seigler H.F.Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg. 1998;88:11-20.
- Long G.V., Margolin K.A. Multidisciplinary approach to brain metastasis from melanoma: the emerging role of systemic therapies. Am Soc Clin Oncol Educ Book. 2013;393-98. Doi: 10.1200/ EdBook_AM.2013.33.393.
- Davies M.A., Liu P., McIntyre S., et al. Prognostic factors for survival in melanoma patients with brain metastases. Cancer 2011;117:1687-96. doi: 10.1002/cncr.25634.
- Raizer J.J., Hwu W.J., Panageas K.S., et al. Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features. Neuro Oncol. 2008;10:199-207. doi: 10.1215/15228517-2007-058.
- Long G.V., Stroyakovskiy D., Gogas H., et al. Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial. Lancet. 2015;386: 444-51. doi: 10.1016/S0140-6736(15) 60898-4.
- Robert C., Karaszewska B., Schachter J., et al. Improved overall survival in melanoma with combined dabrafenib and trametinib. N Engl J Med. 2015;372:30-9. doi: 10.1056/NEJMoa1412690.
- Larkin J., Chiarion-Sileni V., Gonzalez R., et al. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med 2015;373:23-34. doi: 10.1056/NEJMoa1504030.
- Robert C., Schachter J., Long G.V., et al. Pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med. 2015;372:2521-32.
- Ascierto P.A., McArthur G.A., Dreno B., et al. Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial. Lancet Oncol. 2016;17:1248-60. doi: 10.1016/S1470-2045(16)30122-X.
- Davies M.A., Saiag P., Robert C., et.al. Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial. Lancet Oncol. 2017;18(7):863-73. doi: 10.1016/S1470-2045(17)30429-1.